Day(s)
:
Hour(s)
:
Minute(s)
:
Second(s)
Registration
EHES2025 Conference Fee
CATEGORY |
REGISTRATION FEE (Late & Onsite) |
|---|---|
| EHES/EMA Member | AED 2,304 |
| Non Member/ Industry Professionals | AED 3,122 |
| Students | AED 1,285 |
CATEGORY |
DATE |
WORKSHOP REGISTRATION |
|---|---|---|
| EQ-5D Workshop (Prof Paul Kind) | 12:00 PM - 02:00 PM |
2-OCT | AED 500 |
| Clinical Benefit Assessment in the Context of Vale Assessment in HTA: Frameworks, Metrics, Challenges and Evidence (Prof Panos Kanavos and Dr Mackenzie Mills) | 02:00 PM - 05:00 PM |
3- OCT | AED 500 |
- Registration fee entitles participants to attend all the general and concurrent sessions, entrance to the exhibition, daily coffee breaks, daily lunch and conference materials
- Registration fee for Industry Professionals includes a year membership to EMA
- * For administrative purpose a copy of your ID is required as a proof in order to avail the registration fee for EMA Members and Students
- * For EHES/EMA Members you are required to upload a valid membership ID of EMA to avail the registration fee.
CLICK HERE to apply as an EMA Member - **For Students the final confirmation along with the E-Badge will only be sent upon verification of the uploaded ID
Abstract Submission
Language: All abstracts are to be written in English. The Scientific Committee reserves the right to edit abstracts where the English structure makes comprehension difficult.
Submission: All abstracts must be uploaded via the Online Abstract Submission portal in pdf or word format. This should be limited to a maximum of 500 words and should include the following:
- Title of Abstract
- Names and contact details of author(s) {organization, city and country, email, phone numbers, and mailing address}. Please provide a 3-line biography of the author/s with your abstract (not included in the word limit).
- The abstract must include the following headings clearly:
Background, Methods, Results and Discussion - (Please provide evidence of ethical approval and funding acknowledgements, if any)
- Any graphs, charts, diagrams, photos or other forms of display of results can be uploaded separately
- Abstract submission will be acknowledged via email. If you do not receive an email within two (2) weeks of submission or have any additional queries, please contact us by email at admin@ehes.ae
- All abstracts must be submitted on or before 15th September
Scientific Topics are open to Value-Based and Healthcare Financing.
Abstracts must contain original scientific data collected by the author(s). All reports must be based on work that has already been completed. No studies “in progress” will be accepted. Any established research design or method may be used.
Selection Criteria
Abstracts will be evaluated through a blind review process and scored based upon the following criteria to be selected for Oral and Poster/E-Poster Presentations:
- Originality
- Concept and Design
- Presentation
- Clinical Applicability
- Other Characteristics
Terms and Conditions
- The scientific committee reserves the right to make the final decision about the abstract acceptance and its scheduling into the program, based on topics and time constraints.
- The language of the Conference is English.
- All abstracts must be prepared using the abstract submission guidelines.
- Each presenter may submit a maximum of two abstracts.
- Each abstract submission must indicate if the material was published or presented in any other Conference or if it received any awards.
- All presenters must register to attend the Conference within a maximum of 1 week of acceptance of the abstract and be present at the time of the Conference.
- A certificate of appreciation will be given to all the presenters to honour their presentation.
- Presenters must not use the session as a marketing opportunity for products/equipment.
- Conference registration charges will be waived off for accepted poster presenters only (for the Main Author only).
- Payment for travel /accommodation/visa charges is not provided.
International Speakers
Prof Panos Kanavos
International Health Policy Department of Health Policy Programme Director Medical Technologies Deputy Director, LSE Health London School of Economics, UK
Mackenzie Mills
CEO and Founder HTA-Hive London School of Economics and Political Science (LSE) London, UK
Prof Paul Kind
Honorary Professor Health Economics Policy Laboratory University College London, UK
Rafael Pinedo
Associate Professor Senior Health Economist Head, Health Economics & Outcomes Research Group Centre for Statistics in Medicine NDORMS, University of Oxford Deputy Editor, Value in Health Regional Issues
PROF SALAH GHABRI
Scientific Referent in Economic Evaluation of Health Interventions & HTA methods French National Authority for Health (Haute Autorité de Santé, HAS), France
Gluck Michael
MICHAEL E GLUCK PH.D, M.P.P. Vice President AcademyHealth USA
Carroll Aaron
Aaron E. Carroll, MD, MS President and CEO AcademyHealth USA
Mouna Jameleddine
Head of the Health Technology Assessment (HTA) Department Tunisian Authority Assessment & Accreditation in Healthcare (INEAS)
Nabil Harzallah
Head of Unit Department Tunisian Authority Assessment & Accreditation in Healthcare (INEAS)
Amal Yassine
Member of the ISPOR Morocco Chapter Board and General Secretary of the Moroccan Society for Health Products Economics (SMEPS), Morocco
Chakib Boukhalf
ProfessorProfesseur Habilité at Ecole Nationale De Santé Publique (ENSP) Morocco
Regional Speakers
Dr Anas Hamad
PhD, MSc, RPh Director of Pharmacy, NCCCR Head of Medication Safety Quality, HMC Adjunct Assistant Professor, QU Head of Medications Committee, QRCS, Qatar
H.E. Shaikh Mohamed Ebrahim Alkhalifa
Director of Health Strategic Assessment Directorate & Health Economics Program Manager, Supreme Council of Health, Kingdom of Bahrain
Dr Yazeed Al Ruthia
Pharm.D., PhD Associate Professor of Health Policy & Pharmacoeconomics, Director of the Pharmacoeconomics Research Unit, College of Pharmacy, King Saud University
Dr Mariam Al Jalahma
Chief Executive Officer of Government Hospitals, Bahrain
Dr Sultana Al-Sabahi
MSc, PhD, Policy Analyst, Health Economist, Evidence-informed Decision-Making Specialist, Qualitative, Quantitative, and Mixed Method Researcher, HTA, Project Manager, Ministry of Health, Sultanate of Oman
Dr Mohammed Alluhidan
Head of the Health Economics Unit (HEU) Saudi Health Council, Saudi Arabia
Dr Abdullah Alibrahim
Assistant Professor of Industrial & Management Systems Engineering Kuwait University
Said Wani Al Rashdi
Dr Sawsan Abdulkarim
Project Manager Economic Development Board Bahrain
Dr Abdulaziz Alhenaidi
Director of Health Insurance Directorate, Ministry of Kuwait
Dr Mohammad Al Mari
Lecturer in Health Economics Policy & Management Kuwait
Dr Bader AlKhurainej
Venue
Kempinski Central Avenue - 5 star
Set in a modern tower attached to The Dubai Mall, this upscale hotel is a 7-minute walk from the Burj Khalifa skyscraper and 6 km from the Dubai World Trade Centre.
Refined rooms feature balconies with city views, plus flat-screen TVs, iPod docks and free Wi-Fi. Suites add living areas, and some have whirlpool baths and dining rooms. Apartments include kitchens, and 1 has a maid's bedroom. Club rooms provide access to an elegant lounge. Room service is available.
There are 3 bars and 2 chic restaurants, including a refined Arabic eatery and a poolside option. There's also a business centre, a 24-hour fitness centre and a spa with a steam room.
Check-in time: 15:00
Check-out time: 12:00
Sponsors
